Simrat Randhawa
Net worth: 372 040 $ as of 31/05/2026
Net worth: 372 040 $ as of 31/05/2026
Dr. Simrat Randhawa is a Head-Research and Development & Executive VP at Dianthus Therapeutics, Inc. Dr. Randhawa was previously employed as a Senior Vice President-Clinical & Medical Affairs by Aurinia Pharmaceuticals, Inc. and a Head-Medical Affairs by BioMarin Pharmaceutical, Inc. He received his MBA from The Trustees of Columbia University in The City of New York and a doctorate degree from Drexel University College of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/06/2026 | 4,000 ( 0.01% ) | 372 040 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 11/09/2023 |
| Companies | Position | End |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions